


Healthcare Industry NewsFeed
HSMN NewsFeed - 20 Jan 2021
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
Abbott Receives Expanded Medicare Reimbursement for First-Of-Its-Kind MitraClip(TM) Device
HSMN NewsFeed - 20 Jan 2021
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
Haemonetics To Acquire Cardiva Medical, Inc. To Expand Hospital Portfolio
HSMN NewsFeed - 19 Jan 2021
Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
Eitan Medical Receives FDA Clearance for Upgraded Sapphire(TM) Infusion Pump System
HSMN NewsFeed - 19 Jan 2021
Theranica Adds Digital Therapeutics Expert Donald Jones to its Board of Directors
Theranica Adds Digital Therapeutics Expert Donald Jones to its Board of Directors
HSMN NewsFeed - 19 Jan 2021
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
Lilly and Merus NV Announce Collaboration to Discover Novel T-Cell Re-Directing Bispecific Antibodies
HSMN NewsFeed - 18 Jan 2021
New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
New Treatment for Severe Emphysema Now Covered Under Highmark Blue Cross Blue Shield
HSMN NewsFeed - 18 Jan 2021
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
Tessa Therapeutics Receives PRIME Designation from European Medicines Agency for CD30 CAR-T Therapy
HSMN NewsFeed - 15 Jan 2021
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
Lilly Announces $30 Million Limited Partner Investment in Unseen Capital Health Fund
HSMN NewsFeed - 13 Jan 2021
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
EVOQ Therapeutics Announces a License And Collaboration Agreement with Amgen
HSMN NewsFeed - 12 Jan 2021
Conventus-Flower Announces New Executive Vice President of Marketing and R&D
Conventus-Flower Announces New Executive Vice President of Marketing and R&D
HSMN NewsFeed - 12 Jan 2021
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval
HSMN NewsFeed - 11 Jan 2021
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
Valo Raises $190 Million in Series B Financing and Unveils Select Therapeutic Programs
HSMN NewsFeed - 11 Jan 2021
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
CytoSorbents Appoints James Komsa as Vice President - U.S. Sales and Marketing
HSMN NewsFeed - 8 Jan 2021
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly
